Boston Scientific
NYSE:BSXBoston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Banyan Acquisition
NYSE:BYNBanyan Acquisition Corporation does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on identifying business combination targets in the foodservice industry. The company was incorporated in 2021 and is based in Northbrook, Illinois.
Dynacor Group
TSE:DNGDynacor Group Inc. engages in the exploration, development, and mining of minerals properties in Peru. It explores for gold, silver, copper, and other precious metals deposits. The company holds interest in the Tumipampa property covering an area of 7,696 hectares located in Peru. It also holds a 100% interest in the greenfield Anta project that includes eight concessions covering an area of 5,600 hectares situated in Southern Peru. The company was formerly known as Dynacor Gold Mines Inc. and changed its name to Dynacor Group Inc. in June 2022. Dynacor Group Inc. was incorporated in 2006 and is headquartered in Montreal, Canada.